Plasma catecholamines and the counterregulatory responses to hypoglycemia in infants: A critical role for epinephrine and cortisol

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 12, 2004, Pages 6251-6256

  Jackson, Lesley ^a   Williams, Fiona L R ^a   Burchell, Ann ^a   Coughtrie, Michael W H ^a   Hume, Robert ^a,b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; HYDROCORTISONE;

ADRENALIN BLOOD LEVEL; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; INFANT; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; COHORT STUDIES; EPINEPHRINE; FEMALE; FOOD DEPRIVATION; HUMANS; HYDROCORTISONE; HYPOGLYCEMIA; INFANT, NEWBORN; LACTIC ACID; MALE; NOREPINEPHRINE; REGRESSION ANALYSIS;

EID: 10344247652     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0550     Document Type: Article

References (56)

1. Aynsley-Green A, Soltesz G 1985 In: Aynsley-Green A, Chambers TL, eds. Hypoglycaemia in infancy and childhood. Current reviews in paediatrics. Edinburgh: Churchill Livingstone
2. Burchell A, Allan BB, Hume R 1994 The endoplasmic reticulum glucose phosphatase proteins. Mol Membr Biol 11:217-227
3. Chen Y-T, Burchell AM 1995 Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill; 935-965
4. Burchell A, Gibb L, Waddell ID, Giles M, Hume R 1990 The ontogeny of the human hepatic glucose-6-phosphatase proteins. Clin Chem 36:1633-1637
5. Hume R, Lyall H, Burchell A 1992 Impairment of the activity of the microsomal glucose-6-phosphatase system in premature infants. Acta Paediatr 81:580-584
6. Hume R, Burchell A 1993 Abnormal expression of glucose-6-phosphatase in preterm infants. Arch Dis Child 68:202-204
7. van Kempen AAMW, Romijn JA, Ruiter AFC, Endert E, Weverling GJ, Kok JH, Sauerwein HP 2003 Alanine administration does not stimulate gluconeogenesis in preterm infants. Metabolism 52:945-949
8. Lucas A, Morley R, Cole TJ 1988 Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ 297:1304-1308
9. Lyall H, Burchell A, Howie PW, Ogsten S, Hume R 1994 Early detection of metabolic abnormalities in preterm infants impaired by disorders of blood glucose concentration. Clin Chem 40:526-530
10. Duvanel CB, Fawer C-L, Cotting J, Hohlfeld P, Matthieu J-M 1999 Long-term effects of neonatal hypoglycaemia on brain growth and psychomotor development in small-for-gestational-age preterm infants. J Pediatr 134:492-498
11. Cowett RM 1999 Neonatal hypoglycaemia: a little goes a long way. J Pediatr 134:389-391
12. Burchell A, Lyall H, Busuttil A, Bell J, Hume RM 1992 Glucose metabolism and hypoglycaemia in SIDS. J Clin Pathol 45(11 Suppl):39-45
13. Hume R, McGeechan A, Burchell A 1999 Failure to detect preterm infants at risk of hypoglycemia before discharge. J Pediatr 134:499-502
14. Cryer PE 1997 Hypoglycemia, pathophysiology, diagnosis and treatment. New York: Oxford University Press; 85-125
15. Sperling MA, Ganguli S, Leslie N, Landt K 1984 Fetal-perinatal catecholamine secretion: role in perinatal glucose homeostasis. Am J Physiol 247:E69-E74
16. Padbury JF, Martinez AM 1988 Sympathoadrenal system activity at birth: integration of postnatal adaptation. Semin Perinatol 12:163-172
17. Hawdon JM, Weddell A, Aynsley-Green A, Ward Platt MP 1993 Hormonal and metabolic response to hypoglycaemia in small for gestational age infants. Arch Dis Child 68:269-273
18. Ekblad H, Kero P, Korvenranta H, Scheinin M 1992 Sympathoadrenal activity in preterm infants during the first five days of life. Biol Neonate 61:294-301
19. Lagercrantz H, Bistoletti P 1977 Catecholamine release in the newborn infant at birth. Pediatr Res 11:889-893
20. Eliot RJ, Lam R, Leake RD, Hobel CJ, Fisher DA 1980 Plasma catecholamine concentrations in infants at birth and during the first 48 hours of life. J Pediatr 96:311-315
21. Eichler I, Eichler HG, Rotter M, Kyrle PA, Gasic S, Korn A 1989 Plasma concentrations of free and sulfoconjugated dopamine, epinephrine, and norepinephrine in healthy infants and children. Klin Wochenschr 67:672-675
22. Ratge D, Knoll E, Wisser H 1986 Plasma free and conjugated catecholamines in clinical disorders. Life Sci 39:557-564
23. Schwab KO, Breitung B, von Stockhausen HB 1996 Inappropriate secretion of umbilical plasma catecholamines in preterm compared to term neonates. J Perinat Med 24:373-380
24. Burchell A, McGeechan A, Hume R 2000 Therapeutic insulin and hepatic glucose-6-phosphatase enzyme activity in preterm infants. Arch Dis Child Fetal Neonatal Ed 82:F228-F232.
25. Morley R, Brooke OG, Cole TJ, Powell R, Lucas A 1990 Birthweight ratio and outcome in preterm infants. Arch Dis Child 65:30-34
26. Oakley JR, Parsons RJ, Whitelaw AG 1977 Standards for skinfold thickness in British newborn infants. Arch Dis Child 52:287-290
27. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, Kopin IJ 1986 Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 32:2030-2033
28. Bolli GB, Fanelli CG 1999 Physiology of glucose counterregulation to hypoglycemia. Endocrinol Metab Clin North Am 28:467-493
29. Koh THHG, Aynsley-Green A, Tarbit M, Eyre JA 1988 Neural dysfunction during hypoglycaemia. Arch Dis Child 63:1353-1358
30. Cornblath M, Hawdon JM, Williams AF, Aynsley-Green A, Ward-Platt MP, Schwartz R, Kalhan SC 2000 Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics 105:1141-1145
31. Schwartz RP 1997 Neonatal hypoglycaemia: how low is too low? J Pediatr 131:171-173
32. Schwartz NS, Clutter WE, Shah SD, Cryer PE 1987 Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79:777-781
33. Crofton PM, Midgley PC 2004 Cortisol and growth hormone responses to spontaneous hypoglycaemia in infants and children. Arch Dis Child 89:472-478
34. Hughes D, Murphy JF, Dyas J, Robinson JA, Riadfahmy D, Hughes IA 1987 Blood spot glucocorticoid concentrations in ill preterm infants. Arch Dis Child 62:1014-1018
35. Eisenhofer G, Rundquist B, Aneman A, Friberg P, Dakak N, Kopin IJ, Jacobs MC, Lenders JW 1995 Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J Clin Endocrinol Metab 80:3009-3017
36. Goldstein DS, Spanarkel M, Pitterman A, Toltzis R, Gratz E, Epstein S, Keiser HR 1982 Circulatory control mechanisms in vasodepressor syncope. Am Heart J 104:1071-1075
37. Weise M, Merke DP, Pacak K, Walther MM, Eisenhofer G 2002 Utility of plasma free metanephrines for detecting childhood pheochromocytoma. J Clin Endocrinol Metab 87:1955-1960
38. Sacca L, Vigorito C, Cicala M, Corso G, Sherwin R 1983 Role of gluconeogenesis in epinephrine-stimulated hepatic glucose production in humans. Am J Physiol Endocrinol Metab 245:E294-E302
39. Gerich J, Meyer C, Woerle HJ, Stumvoll M 2001 Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 24:382-391
40. Meyer C, Stumvoll M, Welle S, Woerle HJ, Haymond M, Gerich J 2003 Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans. Am J Physiol Endocrinol Metab 285:E819-E826
41. Stumvoll M, Meyer C, Perriello G, Kreider M, Welle S, Gerich J 1998 Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. Am J Physiol Endocrinol Metab 274:E817-E826
42. Cryer PE, Gerich J 1983 Relevance of glucose counter-regulatory systems to patients with diabetes: critical roles of glucagon and epinephrine. Diabetes Care 6:95-99
43. De Feo P, Perriello G, De Cosmo S, Ventura MW, Campbell PJ, Brunetti P, Gerich JE, Bolli GB 1986 Comparison of glucose counter-regulation during short-term and prolonged hypoglycemia in normal humans. Diabetes 35:563-569
44. Pipeleers DG, Schuit FC, Van Schravendijk CF, Van de Winkel M 1985 Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology 117:817-823
45. Taborsky Jr GJ, Ahrén B, Havel PJ 1998 Autonomic mediation of glucagon secretion during hypoglycemia implications for impaired-cell responses in type 1 diabetes. Diabetes 47:995-1005
46. Jackson L, Burchell A, McGeechan A, Hume R 2003 An inadequate glycaemic response to glucagon is linked to insulin resistance in preterm infants? Arch Dis Child Fetal Neonatal Ed 88:F62-F66
47. Chanoine J-P, Rebuffat E, Kahn A, Bergmann P, Van Vleit G 1995 Glucose, growth hormone, cortisol, and insulin responses to glucagon injection in normal infants, aged 0.5-12 months. J Clin Endocrinol Metab 80:3032-3035
48. Weise M, Mehlinger SL, Drinkard B, Rawson E, Charmandari E, Hiroi M, Eisenhofer G, Yanovski JA, Chrousos GP, Merke DP 2004 Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise. J Clin Endocrinol Metab 89:591-597
49. Goldstein DS, Eisenhofer G, Kopin IJ 2003 Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 305:800-811
50. Cryer PE 2001 Hypoglycemia-associated autonomic failure in diabetes. Am J Physiol Endocrinol Metab 281:E1115-E1121
51. Davis SN, Shavers C, Costa F, Mosqueda-Garcia R 1996 Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest 98:680-691
52. Galassetti P, Mann S, Tate D, Neill RA, Costa F, Wasserman DH, Davis SN 2001 Effects of antecedent prolonged exercise on subsequent counterregulatory responses to hypoglycemia. Am J Physiol Endocrinol Metab 280:E908-E917
53. McGregor VP, Banarer S, Cryer PE 2002 Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia. Am J Physiol Endocrinol Metab 282:E770-E777
54. Davis SN, Shavers C, Davis B, Costa F 1997 Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. J Clin Invest 100:429-438
55. Heller SR, Cryer PE 1991 Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in nondiabetic humans. Diabetes 40:223-226
56. Barthel A, Schmoll D 2003 Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 285:E685-E692